Alex Olmedo, MD

Internal Medicine resident. Special interest in infectious diseases. "Medicine is a science of uncertainty and an art of probability".

[Alex Olmedo, MD @AlexOlmedoMD]

We still have a long way to go...
https://t.co/lwMTPfIClD

[Alex Olmedo, MD @AlexOlmedoMD]

Influenza and SARS-CoV-2 are transmitted by respiratory droplets so nonpharmacologic interventions may help to prevent both. We'll need an excellent influenza vaccine coverage, and to identify each virus as they are differently managed #JAMA @JAMA_current https://t.co/Z9wrWiTCR8

[Alex Olmedo, MD @AlexOlmedoMD]

https://t.co/CLxUpmmR8Z

[Alex Olmedo, MD @AlexOlmedoMD]

After the implementation of policies to limit the transmission of SARS-CoV-2 in Taiwan, the activity rates of 5 common infectious diseases were lower than the activity from the 2015-2020 period, suggesting a probable health and economic collateral benefit @CDC_NCEZID @CDCgov

[Alex Olmedo, MD @AlexOlmedoMD]

Algo de buenas noticias al fin! Aún faltan los estudios fase 3, pero esto es prometedor

[The Lancet @TheLancet]

NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT

[Alex Olmedo, MD @AlexOlmedoMD]

Male patient with history of cirrhosis and CKD, construction worker, presents with a 1-week history of pruritic rash, papules, and painful erythema, which rapidly evolved into hemorrhagic bullae. Can you guess the diagnosis? @IDSAInfo #PhotoQuiz
https://t.co/HjmRGWQhPu

[Alex Olmedo, MD @AlexOlmedoMD]

@deepak_dhankani @EricTopol Residents and students spend a lot of time and energy writing progress notes, even more than they do seeing patients. These notes aren't constructed to be read, but to warehouse data
https://t.co/A3rI8oIf9Z

[Alex Olmedo, MD @AlexOlmedoMD]

Asymptomatic COVID-19 patients have a weaker immune response, they shed the virus for longer periods of time and become seronegative at a greater proportion as compared to symptomatic patients @nature
#COVID19 https://t.co/K3oaHhyihf

[Alex Olmedo, MD @AlexOlmedoMD]

A hospital-wide study from Belgium found SARS-CoV-2 IgG antibodies in 6.4% of the staff tested (including clinical and nonclinical staff). Given the low sensitivity of IgM, these antibodies weren't measured @JAMANetwork @JAMA_current
@JAMAInternalMed #jama
https://t.co/geDYLbyBsr

[Alex Olmedo, MD @AlexOlmedoMD]

A new network meta-analysis compared mortality in patients with acute respiratory failure using either noninvasive ventilation or high-flow nasal oxygen vs standard oxygen. Mortality was lower with NIV, but not with HFNO @JAMA_current
@JAMANetwork https://t.co/1TimybzYbe

[Alex Olmedo, MD @AlexOlmedoMD]

A new #RCT published in the @NEJM tested hydroxychloroquine as post-exposure prophylaxis in high and medium risk persons (821 asymptomatic patients) and found no difference in preventing COVID-19 compared to placebo
https://t.co/WCeGhiOQWK

[Alex Olmedo, MD @AlexOlmedoMD]

@CarlosdelRio7 @el_pais @TheLancet @TheLancet ya publicó una versión corregida del estudio. Los resultados y conclusiones no cambiaron.

[Alex Olmedo, MD @AlexOlmedoMD]

@MedinaRiojaMD @aldolaramd Si usas tromboprofilaxis médica en pacientes de moderado a alto riesgo es suficiente, no hay que hacer más. Las medias de compresión siempre han sido patadas de ahogado cuando no puedes utilizar el fármaco

[Alex Olmedo, MD @AlexOlmedoMD]

@doctorthierry @incmnszmx vez*

[Alex Olmedo, MD @AlexOlmedoMD]

CA-125 should only be ordered for monitoring ovarian cancer recurrence and response to treatment. USPSTF and NCCN recommend against ordering it as initial workup of ovarian cancer
#teachable #jama @JAMAInternalMed @JAMAOnc @JAMANetwork
https://t.co/jFcioacOPC

[Alex Olmedo, MD @AlexOlmedoMD]

Residents and students spend a lot of time and energy writing progress notes, even more than they do seeing patients. These notes aren't constructed to be read, but to warehouse data
@JAMANetwork @JAMA_current
https://t.co/A3rI8oIf9Z

[Alex Olmedo, MD @AlexOlmedoMD]

Nice cover!

[The Lancet Microbe @LancetMicrobe]

Our first issue (May 2020) is now live. #SARSCoV2 and #COVID19 inevitably set the tone, as reflected in the amazing artwork on our cover. We also have two research articles on #MCR1 in #Ecoli https://t.co/I1d8H6uBnH [#AMR #OpenAccess #OA]

[Alex Olmedo, MD @AlexOlmedoMD]

The opinion of @PaulSaxMD on taking hydroxychloroquine:
"Personally, I would not take hydroxychloroquine for COVID-19, concerned about side effects and not so sanguine about its potential antiviral activity."